Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-20-066504
Filing Date
2020-05-27
Accepted
2020-05-27 17:26:15
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2021048-3_424b5.htm 424B5 522646
2 GRAPHIC lg_iovance.jpg GRAPHIC 134837
3 GRAPHIC tm2021048d3-tbl_product.jpg GRAPHIC 171690
  Complete submission text file 0001104659-20-066504.txt   946154
Mailing Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070
Business Address 999 SKYWAY ROAD SUITE 150 SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-238724 | Film No.: 20916312
SIC: 2836 Biological Products, (No Diagnostic Substances)